CORONA, Calif., Feb. 7 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that it will host a meeting with financial analysts at 4:30 p.m. Eastern Standard Time on Thursday, February 16, 2006. Watson's senior management will discuss the Company's fourth quarter and full year 2005 financial results, outlook for 2006 and recent corporate developments. The Company plans to release its earnings and outlook on February 16, 2006, following the close of the U.S. financial markets.
The meeting will be webcast live, and can be accessed by logging onto http://www.watsonpharm.com and selecting the analyst conference icon link displayed on the home page, as well as in the Investors section. A live audio broadcast of the analyst meeting can also be accessed by dialing (877) 251-7980, or from international locations, dial (706) 643-1573.
An audio replay of the meeting will also be available beginning approximately two hours after the meeting's conclusion and will remain available through 12:00 midnight Eastern Standard Time on February 24, 2006. The replay may be accessed by dialing (800) 642-1687 and entering access code 4412677. From international locations, the replay may be accessed by dialing (706) 645-9291 and entering the same access code. A replay of the webcast will also be available on Watson's Web site.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc., headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press release and other company information, visit Watson Pharmaceuticals' Web site at http://www.watsonpharm.com.
(Logo: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGO)
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20020214/WATSONLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comWatson Pharmaceuticals, Inc.CONTACT: Investors, Patty Eisenhaur of Watson Pharmaceuticals, Inc.,+1-909-493-5611
Web site: http://www.watsonpharm.com/
